9.3 PBAC commissioned reviews of listed medicines
Page last updated: October 2016
The PBAC may request a focused review of one or more aspects of PBS-listed medicines.
These reviews are conducted in a collaborative and consultative manner, following similar processes to postmarket reviews. These usually have a narrow focus such as examination of cost-effectiveness following release of new evidence, or determining the cost-effectiveness of a listed medicine in a specific group of people.